Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union
Open accessAbstract
BACKGROUND: Trihalomethanes (THMs) are widespread disinfection by-products (DBPs) in drinking water, and long-term exposure has been consistently associated with increased bladder cancer risk. OBJECTIVE: We assessed THM levels in drinking water in the European Union as a marker of DBP exposure and estimated the attributable burden of bladder cancer. METHODS: We collected recent annual mean THM levels in municipal drinking water in 28 European countries (EU28) from routine monitoring records. We estimated a linear exposure-response function for average residential THM levels and bladder cancer by pooling data from studies included in the largest international pooled analysis published to date in order to estimate odds ratios (ORs) for bladder cancer associated with the mean THM level in each country (relative to no exposure), population-attributable fraction (PAF), and number of attributable bladder cancer cases in different scenarios using incidence rates and population from the Global Burden of Disease study of 2016. RESULTS: [standard deviation (SD) of 11.2]. The estimated bladder cancer PAF was 4.9% [95% confidence interval (CI): 2.5, 7.1] overall (range: 0-23%), accounting for 6,561 (95% CI: 3,389, 9,537) bladder cancer cases per year. Denmark and the Netherlands had the lowest PAF (0.0% each), while Cyprus (23.2%), Malta (17.9%), and Ireland (17.2%) had the highest among EU26. In the scenario where no country would exceed the current EU mean, 2,868 (95% CI: 1,522, 4,060; 43%) annual attributable bladder cancer cases could potentially be avoided. DISCUSSION: Efforts have been made to reduce THM levels in the European Union. However, assuming a causal association, current levels in certain countries still could lead to a considerable burden of bladder cancer that could potentially be avoided by optimizing water treatment, disinfection, and distribution practices, among other possible measures. https://doi.org/10.1289/EHP4495.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 56 cited sources checked · 0 supported · 0 flagged
- Findingown data
Twelve countries supplied bromoform and dibromochloromethane measurements.
“12 provided bromoform and dibromochloromethane levels”
Quote in the paperNot a substantial claim - Findingreasoning
The estimated number of bladder cancer cases attributable to THM exposure was 6,561 (95% CI 3,389-9,537) per year.
“accounting for 6,561 (95% CI: 3,389, 9,537) bladder cancer cases per year.”
Quote in the paperSubstantial claim- The authors state this as an assumption: PAF calculations treat everyone as exposed at the country's mean THM concentration, compared with a zero-exposure reference.
- Rests on an assumption: The pooled exposure–response relationship from Costet et al. (2011) applies to European Union populations and to country-specific mean THM levels.
- Rests on an assumption: Routine monitoring THM measurements are representative of residential long-term THM exposure in each country.
- Rests on an assumption: THM concentration is a valid marker or surrogate for total disinfection by-product exposure.
- Findingown data
Romania had the highest estimated THM level, based on data covering 7.4% of its population.
“which was the country with the highest estimated THM level based on data reported for 7.4% of the population”
Quote in the paperNot a substantial claim - Findingown data
The population-weighted mean bromodichloromethane concentration was 2.9 μg/L (SD 3.2; IQR 0.3-6.3).
“2.9μg/L for bromodichloromethane (SD: 3.2; IQR: 0.3–6.3)”
Quote in the paperNot a substantial claim - Findingown data
Average population coverage for bromoform was 70%.
“70% each for bromodichloromethane and bromoform”
Quote in the paperNot a substantial claim
- Findingown data
If no country exceeded the current EU mean THM level, an estimated 2,868 annual attributable bladder cancer cases (95% CI 1,522-4,060; 43%) could potentially be avoided.
“In the scenario where no country would exceed the current EU mean, 2,868 (95% CI: 1,522, 4,060; 43%) annual attributable bladder cancer cases could potentially be avoided.”
Quote in the paperSubstantial claim - Findingown data
The estimated PAF for bladder cancer from THM exposure among both sexes aged ≥20 ranged from 0.01% in Denmark to 23.2% in Cyprus and 30.7% in Romania.
“The estimated population fraction of bladder cancer attributable to THM exposure (both sexes, ≥20-y age group) ranged from 0.01% (95% CI: 0.004, 0.013) in Denmark to 23.2% (95% CI: 12.4, 32.7) in Cyprus and 30.7% (95% CI: 16.8, 42.3) in Romania”
Quote in the paperSubstantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Findingown data
Maximum reported THM concentrations exceeded the EU regulatory limit of 100 μg/L in 9 of 22 countries with available data.
“Maximum reported concentrations exceeded the EU regulatory limit (100μg/L) for 9 of 22 countries with available data (Table 2).”
Quote in the paperNot a substantial claim - Findingown data
Average population coverage for dibromochloromethane was 71%.
“71% for dibromochloromethane”
Quote in the paperNot a substantial claim - Findingown data
Generalized additive models showed no significant departure from linearity for the exposure-response association (p=0.1461).
“These models showed no significant departure from linearity (p=0.1461) (see Figure S1), and we used logistic regression to estimate country-specific ORs and 95% CIs.”
Quote in the paperSubstantial claim - Findingown data
Among the 14 countries with data, average population coverage for chloroform was 72%.
“The average population coverage among the 14 countries with available data was 72% for chloroform”
Quote in the paperNot a substantial claim - Findingcitation
The estimated OR for bladder cancer was 1.004 (95% CI 1.002-1.006) for each 1-μg/L rise in THM among men and women together, with adjustment for study centre, age, sex, education, smoking, high-risk job, fluid intake, and coffee consumption.
“We derived an odds ratio (OR) of 1.004 (95% CI: 1.002, 1.006) for a 1-μg/L increase in THM in men and women combined, adjusted for study center, age, sex, educational level, smoking status, high-risk occupation, daily fluid intake, and”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Costet et al. (2011)
Not checked in the free run.
- Findingown data
The total estimated number of bladder cancer cases per year attributable to THM exposure in the EU was 6,561 (95% CI 3,389, 9,537).
“In total, we estimated that 6,561 bladder cancer cases per year (95% CI: 3,389, 9,537) would be attributable to THM exposure in the European Union”
- Also stated in: § Discussion · plain
“or 6,561 cases (95% CI: 3,389; 9,537)”
Quote in the paperSubstantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Also stated in: § Discussion · plain
- Findingown data
For nine countries, only national mean THM values were available, preventing calculation of a population-weighted mean.
“Nine countries (Croatia, Denmark, Finland, Germany, Hungary, Malta, the Netherlands, Slovakia, and Sweden) provided mean THM data at the national level; hence, the population-weighted mean could not be calculated.”
Quote in the paperNot a substantial claim - Findingown data
No THM data could be found for Bulgaria.
“We could not find THM data for Bulgaria.”
Quote in the paperNot a substantial claim - Findingown data
The population-weighted mean chloroform concentration was 6.8 μg/L (SD 6.1; IQR 1.6-14.2).
“The population-weighted average was 6.8μg/L for chloroform (SD: 6.1; IQR: 1.6–14.2)”
Quote in the paperSubstantial claim - Findingown data
Estimated annual bladder cancer cases attributable to THM exposure ranged from zero in Denmark to 1,482 in Spain.
“The estimated annual bladder cancer cases attributable to THM exposure ranged from zero in Denmark to 1,482 in Spain”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Findingown data
Average population coverage for bromodichloromethane was 70%.
“70% each for bromodichloromethane and bromoform”
Quote in the paperNot a substantial claim - Findingcitation
Romanian THM measurements published between 2006 and 2015 were available for eight cities and small supply zones in ten counties.
“In Romania, we obtained published THM data from 2006–2015 for 8 individual cities and for small supply areas in 10 counties (Cohl et al. 2015; Dirtu et al. 2016; Kovacs et al. 2007; Thach et al. 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Cohl et al. 2015
Not checked in the free run.
- cites Dirtu et al. 2016
Not checked in the free run.
- cites Kovacs et al. 2007
Not checked in the free run.
- Findingreasoning
This total represented 4.9% (95% CI 2.5, 7.1) of annual bladder cancer cases in the ≥20 age group.
“which represents 4.9% (95% CI: 2.5, 7.1) of the total annual bladder cancer cases in this age group”
- Also stated in: § Discussion · hedged
“and a PAF of 4.9% (95% CI: 2.5, 7.1; country-specific range: 0–23%)”
Quote in the paperSubstantial claim- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Also stated in: § Discussion · hedged
- Findingown data
The population-weighted mean dibromochloromethane concentration was 2.3 μg/L (SD 2.2; IQR 0.5-4.3).
“2.3μg/L for dibromochloromethane (SD: 2.2, IQR: 0.5–4.3)”
Quote in the paperNot a substantial claim - Findingown data
Austria was assigned a mean THM concentration of 1.1 μg/L (SD 5.9) from the literature search.
“Based on the literature search, we assigned Austria a mean (SD) THM level of 1.1μg/L (5.9)”
Quote in the paperSubstantial claim - Findingown data
Most participating countries relied on chlorination-chlorine or hypochlorite-as their primary disinfectant, either alone or alongside other treatments.
“The vast majority of participating countries use chlorination (chlorine, hypochlorite) as the main disinfection method alone or in combination with other methods (ozone, UV radiation, etc.).”
Quote in the paperNot a substantial claim - Findingown data
The population-weighted mean bromoform concentration was 1.9 μg/L (SD 2.5; IQR 1.1-2.5).
“1.9μg/L for bromoform (SD: 2.5; IQR: 1.1–2.5)”
Quote in the paperSubstantial claim - Findingown data
The high-exposure scenario (mean+SD; EU mean 22.9 μg/L) yielded 12,101 (95% CI 6,351, 17,346) estimated attributable cases per year among men and women ≥20.
“Replacing country-specific mean THM values with alternative low-exposure (mean−SD or 0 if negative, resulting EU mean=0.5μg/L) and high-exposure (mean+SD; EU mean=22.9μg/L) scenarios resulted in 1,907 (95% CI: 972, 2,808) and 12,101 (95% CI: 6,351, 17,346) estimated attributable cases per year, respectively, among men and women ≥20 years of age”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Findingown data
In the 30-79 age group, attributable cases ranged from 1,308 (95% CI 667, 1,925) in the lowest-exposure scenario to 8,334 (95% CI 4,387, 11,918) in the highest-exposure scenario.
“Similarly, in the 30- to 79-y age group, the number of attributable cases ranged from 1,308 (95% CI: 667, 1,925) in the lowest-exposure scenario to 8,334 (95% CI: 4,387, 11,918) in the highest-exposure scenario”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Findingown data
This reduction was 43.7% relative to the primary estimate for men and women ≥20.
“a 43.7% reduction relative to the primary estimate for men and women ≥20 years of age”
Quote in the paperNot a substantial claim- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Findingown data
Reducing mean THM values to the current EU mean (11.7 μg/L) for 13 higher-exposure countries reduced estimated attributable cases by 2,868 per year (95% CI 1,522, 4,060).
“Reducing estimated mean THM values to the current EU mean (11.7μg/L) for 13 countries with higher THM exposures reduced the estimated number of attributable cases by 2,868 per year (95% CI: 1,522, 4,060)”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Findingown data
Among men and women aged 30-79, the estimated number of bladder cancer cases per year attributable to THM exposure in the EU was 4,518 (95% CI 2,339, 6,555).
“For men and women 30–79 years of age, we estimated that 4,518 bladder cancer cases per year (95% CI: 2,339, 6,555) would be attributable to THM exposure in the European Union as a whole”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Findingown data
The corresponding PAF was 4.2% (95% CI 2.2, 6.2).
“with a PAF of 4.2% (95% CI: 2.2, 6.2)”
Quote in the paperNot a substantial claim- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Findingown data
The estimated annual average THM level was 11.7 μg/L (SD 11.2).
“We estimated an annual average THM level of 11.7μg/L (SD: 11.2)”
Quote in the paperSubstantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Findingown data
Only 5 of 26 countries with monitoring data had annual THM averages above 25 μg/L: Cyprus, Malta, Ireland, Spain, and Greece.
“The annual THM average was above 25μg/L in only 5 of 26 countries with monitoring data: Cyprus, Malta, Ireland, Spain, and Greece.”
Quote in the paperSubstantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Findingcitation
This French estimate is lower than the estimate by Corso et al. (2017), which had a PAF of 16% and 1,485 attributable cases per year.
“which is lower than estimates reported by Corso et al. (2017) (PAF=16%; 1,485 attributable cases/year)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Corso et al. (2017)
Not checked in the free run.
- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Findingreasoning
This represented 4.9% (95% CI 2.6, 7.1) of all EU bladder cancer cases in that age group.
“accounting for 4.9% (95% CI: 2.6, 7.1) of all EU bladder cancer cases among men and women in this age group”
Quote in the paperNot a substantial claim- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Findingown data
In the sensitivity analysis assigning the EU26 mean (11.7 μg/L) to countries with <50% coverage, the estimated attributable cases in the EU (both sexes ≥20) were 5,711 (95% CI 2,908, 8,414).
“the number of attributable cases in the European Union (both sexes, ≥20-y age group) was estimated to be 5,711 (95% CI: 2,908, 8,414) cases”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Findingown data
The precision of the exposure-response relationship decreases at higher exposure levels because statistical power is smaller at the higher-exposure end.
“Additionally, the precision of the exposure–response relationship decreases at higher exposure levels, given the smaller statistical power at the higher-exposure end, as shown in Figure S1.”
Quote in the paperNot a substantial claim - Findingown data
In the 30-79 age group, 2,016 (95% CI 1,074, 2,843) annual attributable bladder cancer cases would be avoided.
“In the 30- to 79-y age group, 2,016 (95% CI: 1,074, 2,843) annual attributable bladder cancer cases would be avoided”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Findingown data
The low-exposure scenario (mean−SD or 0 if negative; EU mean 0.5 μg/L) yielded 1,907 (95% CI 972, 2,808) estimated attributable cases per year among men and women ≥20.
“Replacing country-specific mean THM values with alternative low-exposure (mean−SD or 0 if negative, resulting EU mean=0.5μg/L) and high-exposure (mean+SD; EU mean=22.9μg/L) scenarios resulted in 1,907 (95% CI: 972, 2,808) and 12,101 (95% CI: 6,351, 17,346) estimated attributable cases per year, respectively, among men and women ≥20 years of age”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Findingnone given
In Greece, THM data were not available for large cities including Thessaloniki and Larisa.
“Similarly in Greece, for large cities including Thessaloniki and Larisa, THM data were not available.”
Quote in the paperNot a substantial claim - Findingown data
For Romania, using the EU mean instead of the original estimate markedly reduced the estimated PAF and attributable cases.
“In particular, the data for Romania are a limitation, and the estimated PAF and attributable cases for Romania were markedly reduced when using the EU mean in place of the original estimate.”
Quote in the paperNot a substantial claim - Findingown data
Using the EU mean for countries with less than 50% coverage (Greece, Italy, Romania, and the United Kingdom) resulted in a net decrease in the overall PAF and attributable case estimates.
“In addition, using the EU mean for all countries with <50% coverage (Greece, Italy, Romania, and the United Kingdom) resulted in a net decrease in the overall PAF and attributable case estimates.”
Quote in the paperNot a substantial claim - Premisecitation
Long-term exposure to trihalomethanes is consistently associated with an increased risk of bladder cancer.
“long-term exposure has been consistently associated with increased bladder cancer risk.”
- Also stated in: § Introduction · boosted
“Different meta-analyses and pooled analyses (Costet et al. 2011; King and Marrett 1996; Villanueva et al. 2003, 2004) of studies in Europe and North America provide consistent evidence that long-term exposure to THMs, used as a surrogate of DBPs, is associated with an increased bladder cancer risk.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Costet et al. 2011
Not checked in the free run.
- cites King and Marrett 1996
Not checked in the free run.
- cites Villanueva et al. 2003, 2004
Not checked in the free run.
- Also stated in: § Introduction · boosted
- Premisecitation
Epidemiological studies in different European settings show large variability in THM levels within and between countries.
“Epidemiological studies conducted in different European settings indicate large variability in the levels within (Villanueva et al. 2017) and between (Jeong et al. 2012) countries.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Villanueva et al. 2017
Not checked in the free run.
- cites Jeong et al. 2012
Not checked in the free run.
- Premisecitation
Men exposed to annual mean THM levels above 25 μg/L had a 35% higher bladder cancer risk than those exposed to levels below 5 μg/L.
“In the most recent international meta-analysis of case–control studies, men exposed to annual mean THM levels >25μg/L had a 35% increased bladder cancer risk [95% confidence interval (CI): 9, 66]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Costet et al. 2011
Not checked in the free run.
- Premisecitation
The epidemiological evidence concerning cancer sites other than bladder is inconsistent.
“and the epidemiological evidence concerning other cancer sites is inconsistent (Villanueva et al. 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Villanueva et al. 2015
Not checked in the free run.
- Premisecitation
Men exposed to annual mean THM levels above 50 μg/L had a 51% higher bladder cancer risk than those exposed to levels below 5 μg/L.
“and those exposed to >50μg/L had a 51% increased risk (95% CI: 26, 82) compared to levels <5μg/L (Costet et al. 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Costet et al. 2011
Not checked in the free run.
- Premisecitation
For the exposure-response function, the authors used Costet et al. (2011), which they called the most recent and complete epidemiological dataset linking residential THM exposure to bladder cancer.
“The exposure–response function was based on data from Costet et al. (2011), the most recent and complete epidemiological data set on the relationship between residential THM exposure and bladder cancer.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Costet et al. (2011)
Not checked in the free run.
- Premisecitation
A 2010 HIWATE report found THM concentrations across seven cities in five European countries spanning from undetectable in Modena, Italy, to over the then-current regulatory ceiling in Barcelona, Spain.
“The European research project Health impacts of long-term exposure to disinfection by-products in drinking water (HIWATE) reported that in 2010, THM levels in drinking water in seven cities from five European countries ranged from below the limit of detection (Modena, Italy) to above the current regulatory maximum limit (Barcelona, Spain) (Jeong et al. 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jeong et al. 2012
Not checked in the free run.
- Premisecitation
Few large cohort studies have prospectively assessed the link with bladder cancer strongly enough to conclude causality.
“However, there are limited large cohort studies prospectively evaluating the association with bladder cancer to unequivocally conclude a causal association”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Villanueva et al. 2015
Not checked in the free run.
- Study design and conductown data
The completeness and precision of the data varied across countries.
“Data coverage and accuracy were heterogeneous among countries.”
Quote in the paperNot a substantial claim - Premisenone given
THMs have been used in epidemiological studies as surrogates for total DBP content.
“THMs have been used in epidemiological studies as surrogates of total DBP content.”
Quote in the paperSubstantial claim- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Premisecitation
In a study of 49 adults, micronuclei counts in peripheral lymphocytes and urine mutagenicity were associated with higher levels of individual brominated THMs in exhaled breath after 40 minutes of swimming.
“In addition, a study of 49 adults reported that micronuclei counts in peripheral lymphocytes and urine mutagenicity were associated with higher levels of individual brominated THMs in exhaled breath following 40 min of swimming (Kogevinas et al. 2010)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kogevinas et al. 2010
Not checked in the free run.
- Premisecitation
THMs are not the most toxic DBPs.
“they are not the most toxic (Plewa et al. 2008)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Plewa et al. 2008
Not checked in the free run.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Interpretationcitation
Future burden estimates are subject to error from changes in population structure and bladder cancer incidence rates.
“For future estimates, sources of error include changes in population structure and incidence rates, since the European population is growing and getting older (Eurostat), and the bladder cancer incidence is expected to increase in some European countries and decrease in others over the next decade (Antoni et al. 2017; Wong et al. 2018).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Eurostat
Not checked in the free run.
- cites Antoni et al. 2017
Not checked in the free run.
- cites Wong et al. 2018
Not checked in the free run.
- Premisecitation
Each chemical or disinfection process contributes to the formation of other disinfectant-specific by-products.
“However, each chemical or disinfection process contributes to the formation of other disinfectant-specific by-products”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Kristiana et al. 2013
Not checked in the free run.
- cites Richardson et al. 2000
Not checked in the free run.
- cites Sorlini et al. 2014
Not checked in the free run.
- Premisecitation
Many disinfection by-products have been classified as mutagenic or genotoxic based on in vitro assays or animal studies.
“Many DBPs have been classified as mutagenic or genotoxic based on in vitro assays or experimental studies of animals (Richardson et al. 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Richardson et al. 2007
Not checked in the free run.
- Interpretationnone given
Recent THM measurements do not necessarily represent past exposures.
“Thus, our estimations should be interpreted as future projections rather than estimates of the actual burden of disease, since recent THM data do not necessarily reflect past exposures.”
Quote in the paperSubstantial claim - Premisecitation
Correlations between THMs and specific DBPs vary.
“correlations with specific DBPs are variable (Villanueva et al. 2012)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Villanueva et al. 2012
Not checked in the free run.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Interpretationreasoning
Because Bulgaria accounts for only 1.5% of the EU population, assigning the EU mean for Bulgaria has little influence on the overall European estimates.
“In addition, for Bulgaria, we could not find any published data at all, and we assigned the EU mean, but it is a small country (1.5% of the EU population) and therefore has little influence in the overall European estimates.”
Quote in the paperNot a substantial claim - Study design and conductown data
The analysis did not account for DBP exposure through inhalation and dermal routes during cleaning, showering, bathing, or swimming, which contributes to increased THM exposure.
“nor the exposure to DBPs through inhalation and dermal exposure during household cleaning activities (Charisiadis et al. 2014), showering or bathing, or in swimming pools (Villanueva et al. 2007), which contributes to increased THM exposure”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Charisiadis et al. 2014
Not checked in the free run.
- cites Villanueva et al. 2007
Not checked in the free run.
- Interpretationreasoning
The burden estimates should be interpreted as future projections rather than as estimates of the actual burden of disease, because recent THM data may not reflect past exposures.
“Thus, our estimations should be interpreted as future projections rather than estimates of the actual burden of disease, since recent THM data do not necessarily reflect past exposures.”
Quote in the paperSubstantial claim - Premisenone given
Most case-control studies included in the pooled analysis report a null or inverse association between THMs and bladder cancer among women.
“While most of the case–control studies included in the pooled analysis report a null or inverse association among women”
Quote in the paperNot a substantial claim - Premisenone given
An exposure-response relationship is available only for total THMs.
“However, the exposure–response relationship is only available for total THMs.”
Quote in the paperSubstantial claim- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
- Interpretationreasoning
If Romanian THM levels were overestimated, attributable bladder cancer cases would be overestimated for Romania and for the EU as a whole.
“if THM levels were overestimated for Romania, attributable bladder cancer cases would have been overestimated for the country and for the European Union as a whole.”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Interpretationreasoning
The lower precision at high exposure may lead to inaccurate burden estimates in countries with high THM levels.
“This may lead to inaccurate estimates in countries with high THM levels.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
Reliance on monitoring data covering 75% of the population may cause exposure misclassification and over- or underestimation of the THM average.
“Potential exposure misclassification may result from reliance on monitoring data covering 75% of the population that may lead both to over- or underestimation of the THM average.”
Quote in the paperSubstantial claim - Interpretationown data
The impact of noncovered populations on the EU population-weighted THM estimate cannot be generalized or anticipated because this information is not available for all countries.
“However, we do not have this type of information for all the countries, and we cannot generalize and anticipate the impact on the EU population-weighted THM estimate.”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 21
- May combine two claims. 41
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFourteen countries supplied chloroform measurements.
“A total of 14 countries provided chloroform levels”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCoverage of the population across the 26 countries varied from 22% in Italy to 100% elsewhere, averaging 80%.
“The population coverage among the 26 countries, shown in Table 2, ranged from 22% in Italy to 100% in different countries (average coverage: 80%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSpain (22.6%), the UK (20.7%), and Romania (16.0%) contributed the largest estimated numbers of attributable cases.
“Spain (22.6%), the United Kingdom (20.7%), and Romania (16.0%) accounted for the largest estimated number of attributable cases.”
- Also stated in: § Discussion · plain
“Spain was the country with the greatest estimated contribution (23% of attributable EU cases) followed by the United Kingdom (21%) and Romania (16%)”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
- Also stated in: § Discussion · plain
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenDenmark mainly relies on aeration and filtration, whereas the Netherlands applies ozone and UV radiation.
“In Denmark, aeration and filtration are mainly used, and in the Netherlands, ozone and UV radiation are applied.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataItaly also uses chlorine dioxide; in Lithuania, chlorination is limited to half of one city and that city uses surface water.
“Chlorine dioxide is additionally used in Italy, and in Lithuania, chlorine is used only in half of one of the cities and is supplied with surface water.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDenmark had the lowest mean THM level (0.02 μg/L), followed by the Netherlands (0.2), Germany (0.5), Lithuania (1.0), Austria (1.1), Slovenia (2.9), Italy (3.1), and Poland (5.7 μg/L).
“The lowest mean THM values were observed in Denmark (0.02μg/L), the Netherlands (0.2μg/L), Germany (0.5μg/L), Lithuania (1.0μg/L), Austria (1.1μg/L), Slovenia (2.9μg/L), Italy (3.1μg/L), and Poland (5.7μg/L).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe overall estimated PAF for bladder cancer from THM exposure was 4.9% (95% CI 2.5-7.1), ranging across countries from 0% to 23%.
“The estimated bladder cancer PAF was 4.9% [95% confidence interval (CI): 2.5, 7.1] overall (range: 0–23%)”
Quote in the paperSubstantial claim- The authors state this as an assumption: PAF calculations treat everyone as exposed at the country's mean THM concentration, compared with a zero-exposure reference.
- Rests on an assumption: The pooled exposure–response relationship from Costet et al. (2011) applies to European Union populations and to country-specific mean THM levels.
- Rests on an assumption: Routine monitoring THM measurements are representative of residential long-term THM exposure in each country.
- Rests on an assumption: THM concentration is a valid marker or surrogate for total disinfection by-product exposure.
May combine two claims.
Findingown dataThe lowest PAFs were in Denmark and the Netherlands (0.0% each); the highest among EU26 were Cyprus (23.2%), Malta (17.9%), and Ireland (17.2%).
“Denmark and the Netherlands had the lowest PAF (0.0% each), while Cyprus (23.2%), Malta (17.9%), and Ireland (17.2%) had the highest among EU26.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRoutine monitoring supplied THM data for 26 of the 28 EU countries, covering 75% of the EU26 population; the years were 2005-2018, except Austria, which dated from 1997.
“We obtained recent (2005–2018) information—with the exception of Austria (1997)—on THM levels in drinking water through routine monitoring for 26 of the 28 countries in the European Union (Table 2), covering 75% of the EU26 population.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRomania's mean THM concentration from published studies was 91.8 μg/L (SD 64.2), but only 7.4% of the population was covered.
“For Romania, the estimated mean (SD) from the published studies was 91.8μg/L (64.2), but the population coverage was limited (7.4%)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThirteen countries supplied bromodichloromethane measurements.
“13 provided bromodichloromethane levels”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCyprus had the highest mean THM level (66.2 μg/L), then Malta (49.4), Ireland (47.3), Spain (28.8), and Greece (26.3 μg/L).
“The highest mean THM values were observed in Cyprus (66.2μg/L), Malta (49.4μg/L), Ireland (47.3μg/L), Spain (28.8μg/L), and Greece (26.3μg/L) (Figure 1).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationFew samples exceeded the limit; among the nine countries, noncompliance averaged 0.7% overall, 0.3% for large systems, and 1.1% for small systems.
“However, the proportion of samples exceeding this limit was low, and average noncompliance in the nine countries was 0.7% overall, 0.3% in large water systems, and 1.1% in small water systems (EIONET).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EIONET
Not checked in the free run.
May combine two claims.
Findingown dataMeasured THM values spanned from 0.0 μg/L in several countries up to 301 μg/L in Portugal, 439 μg/L in Spain, and 771 μg/L in Hungary; the Hungarian value was a single confirmed atypical result.
“The actual measurements ranged from 0.0μg/L in multiple countries to 301μg/L in Portugal, 439μg/L in Spain, and 771μg/L in Hungary (corresponding in this last case to one confirmed and atypical observation).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe population-weighted mean THM level among the 26 countries was 11.7 μg/L, with SD 11.2, median 10, and IQR 3.1-24.2.
“The estimated population-weighted mean THM level was 11.7μg/L [standard deviation (SD) of 11.2].”
- Also stated in: § Trihalomethane Levels · plain
“Among these countries, the population-weighted mean THM level was 11.7μg/L [SD: 11.2, median: 10, interquartile range (IQR): 3.1–24.2].”
Quote in the paperNot a substantial claim- Also stated in: § Trihalomethane Levels · plain
May combine two claims.
Findingnone givenBulgaria received the EU26 mean THM concentration of 11.7 μg/L and SD 11.2.
“the EU26 mean to Bulgaria (11.7μg/L) and SD (11.2)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThis study is the first Europe-wide assessment of THM levels in drinking water and of the THM-attributable bladder cancer burden, using monitoring data covering 75% of the population in 26 EU countries.
“We conducted the first Europe-wide assessment of THM levels in drinking water and estimated the THM-attributable burden of bladder cancer using monitoring data covering 75% of the population in 26 EU countries.”
Quote in the paperSubstantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
May combine two claims.
Findingown dataThe estimated PAF for France was 4.6%, corresponding to 737 attributable cases per year.
“We estimated a PAF of 4.6% for France (737 attributable cases/year)”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
May combine two claims.
Findingown dataThe largest absolute reductions would be in Romania (891 cases), Spain (860 cases), and the UK (685 cases).
“The largest absolute reduction would occur in Romania (891 cases), Spain (860 cases), and the United Kingdom (685 cases).”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
May combine two claims.
Findingown dataThe largest relative reductions were in Romania (85.1%), Cyprus (80.3%), Malta (74.5%), and Ireland (73.5%).
“The largest reduction relative to the current number of attributable cases occurred in Romania (85.1%), Cyprus (80.3%), Malta (74.5%), and Ireland (73.5%).”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationIn France, bladder cancer cases in 2011 among men were considerably lower (n=9,100) than the Global Burden of Disease 2016 estimates for 2016 among men (n=13,959).
“In the French study, for example (Corso et al. 2017), bladder cancer cases were considerably lower in all ages (n=9,100 in 2011, men only) than the ones reported in the Global Burden of Disease 2016 study (n=13,959 in 2016, men only).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Corso et al. 2017
Not checked in the free run.
May combine two claims.
Findingown dataIn the Czech Republic, 94% of the population is served by public water supply systems, but THM data were available for only 74%.
“For example, in the Czech Republic, 94% of the population is served by public water supply systems, but we had THM data only for 74%.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor Italy, websites covering 54% of the population were checked, and only 35% of these included THM information.
“For example, for Italy, we checked relevant websites covering 54% of the Italian population, and, of these, only 35% included THM information.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNot all municipalities or water utilities report water quality analysis results, and among those that do, only a subset includes THM values.
“Not all municipalities or water utilities report their water quality analysis results, and among the ones that do, only a subset includes THMs values.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn the EU, total THMs and bromate are the sole regulated DBPs; the regulatory maximum is 100 μg/L.
“Together with bromate, total THM concentrations representing the sum of chloroform, bromodichloromethane, dibromochloromethane, and bromoform are the only DBPs regulated in the European Union, with a maximum contaminant level of 100μg/L (EC 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EC 1998
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTHM variability was attributed mainly to differences in source-water properties, disinfection practices, and distribution-system conditions.
“This variability was based primarily on variations in the characteristics of raw water, drinking water disinfection methods, and conditions of the water distribution system (Charisiadis et al. 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Charisiadis et al. 2015
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrior burden estimates for France and the United States suggest that about one-sixth of bladder cancer incidence is attributable to drinking-water DBP exposure.
“Burden of disease estimates for bladder cancer due to DBP exposure have been previously assessed in France (Corso et al. 2017) and the United States (Regli et al. 2015; U.S. EPA 2005), indicating that around 16% of bladder cancer incidence is currently attributable to exposure to DBPs in drinking water.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Corso et al. 2017
Not checked in the free run.
- cites Regli et al. 2015
Not checked in the free run.
- cites U.S. EPA 2005
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataCountries differ in water testing collection points and in the geographical level used to report THM levels.
“Some differences between countries are also present in the various water testing collection points and the geographical level for reporting THM levels (Table 1).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataData on showering, bathing, or swimming were incomplete across studies and were therefore omitted from the analysis.
“Showering, bathing, or swimming information was not available for all studies and was not included in the analysis.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe pooled dataset contained 9,458 people with long-term residential THM estimates: 3,481 cases and 5,977 controls, aged 30-80, each with THM information covering at least 70% of a 40-year exposure period.
“We pooled data from 9,458 subjects with estimates of long-term average residential THM levels, including 3,481 cases (2,776 men, 705 women) and 5,977 controls (4,199 men, 1,778 women) 30–80 years of age with THM data for ≥70% of the 40-y exposure window.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Costet et al. (2011)
Not checked in the free run.
May combine two claims.
PremisereasoningAustria was expected to have very low THMs, as nearly all its drinking water is groundwater and UV treatment predominates.
“The literature search identified reports of THM levels measured before the year 2000 for Austria (Premazzi et al. 1997), where expected THM levels are very low, since 99.7%% of drinking water is from underground sources and ultraviolet (UV) radiation is the predominant disinfection method (A Indra, personal communication).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Premazzi et al. 1997
Not checked in the free run.
May combine two claims.
Interpretationown dataIf the association is causal, present THM concentrations in some countries may produce a substantial bladder cancer burden, much of which might be preventable through better water treatment, disinfection, and distribution, among other measures.
“However, assuming a causal association, current levels in certain countries still could lead to a considerable burden of bladder cancer that could potentially be avoided by optimizing water treatment, disinfection, and distribution practices, among other possible measures.”
Quote in the paperSubstantial claim- The authors state this as an assumption: THM exposure is causally associated with bladder cancer.
May combine two claims.
PremisecitationCostet et al. (2011) pooled and meta-analysed six case-control studies, with two based in the United States and one each in Canada, France, Finland, and Spain.
“This is an international pooled analysis and meta-analysis including six case–control studies: two from the United States (Cantor et al. 1998; Lynch et al. 1989) and one each from Canada (King and Marrett 1996), France (Cordier et al. 1993), Finland (Koivusalo et al. 1998), and Spain (Villanueva et al. 2007).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Costet et al. (2011)
Not checked in the free run.
- cites Cantor et al. 1998
Not checked in the free run.
- cites Lynch et al. 1989
Not checked in the free run.
May combine two claims.
PremisecitationMost DBPs are unregulated; many are considered carcinogenic or genotoxic and have been linked to bladder cancer, such as nitrosamines, but their health effects are insufficiently studied.
“Most of them are not regulated, and many are considered carcinogenic and/or genotoxic and have been associated with bladder cancer (e.g., nitrosamines) (Richardson et al. 2007), but their effect on human health has not been sufficiently studied.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Richardson et al. 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn a study of 43 adults, changes in exhaled DBPs after a 40-minute swim in a chlorinated pool were associated with microRNA and gene expression patterns that may indicate increased bladder cancer risk.
“while another study of 43 adults (Espín-Pérez et al. 2018) reported that changes in exhaled DBPs following a 40-min swim in a chlorinated pool were associated with microRNA and gene expression patterns that may indicate an increased risk of bladder cancer.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Espín-Pérez et al. 2018
Not checked in the free run.
May combine two claims.
Study design and conductcitationThe analysis did not account for bottled or filtered water use, which may be substantial in some countries and may cause exposure misclassification through ingestion.
“We have not considered the proportion of use of bottled or filtered water, which, in some countries, may be substantial and account for exposure misclassification through the ingestion route (Wright et al. 2006)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wright et al. 2006
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPolymorphisms in DBP-metabolizing genes modify the exposure-response relationship.
“Polymorphisms in DBP-metabolizing genes have been shown to modify the exposure–response relationship (Cantor et al. 2010)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cantor et al. 2010
Not checked in the free run.
May combine two claims.
InterpretationreasoningUncertainties remain in the THM-bladder cancer association: the causal agent is unidentified, biological pathways are not fully established, and the inconsistent association in women is not well understood.
“However, some uncertainties in the association still exist, e.g., the putative agent(s) is yet to be identified, the biological pathways are not completely established, and the inconsistent association in some studies in women is not well understood.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe European population is growing and aging.
“since the European population is growing and getting older (Eurostat)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Eurostat
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPrevious European studies found THM levels similar to this study's in Italy, Lithuania, Spain, and the UK, but lower in Crete, Greece, and higher in Rennes, France, than the national averages reported here.
“Previous studies in European regions found THM levels similar to the ones in our study in Italy, Lithuania, Spain, and the United Kingdom, but Greece (the island of Crete) showed lower levels, and France (Rennes region) showed higher levels than the national averages reported in the present study (Goslan et al. 2014; Krasner et al. 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Goslan et al. 2014
Not checked in the free run.
- cites Krasner et al. 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn 2016, the EU had 135,011 bladder cancer cases, of which 134,976 (99.97%) were in the ≥20 age group.
“In 2016, a total of 135,011 bladder cancer cases occurred in the European Union, of which 134,976 (99.97%) were in the ≥20-y age group (IHME 2016a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites IHME 2016a
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationDBPs are a complex mixture of hundreds of chemicals.
“DBPs constitute a complex mixture of hundreds of chemicals (Richardson et al. 2007)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Richardson et al. 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenPopulation differences in DBP-metabolizing gene polymorphisms are unlikely to affect the overall results.
“but these population differences are unlikely to affect our overall results.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataNo published THM data were available for Bulgaria, so the EU mean was assigned for that country.
“In addition, for Bulgaria, we could not find any published data at all, and we assigned the EU mean, but it is a small country (1.5% of the EU population) and therefore has little influence in the overall European estimates.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe large contributions of Spain, the UK, and Romania are explained mainly by high incidence rates (Spain, Romania), large population size (UK), or high average THM levels (Romania).
“explained largely by high incidence rates (Spain, Romania), large population size (the United Kingdom ranks the second EU country in inhabitants), or high average THM levels (Romania).”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
- Rests on an assumption: The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
May combine two claims.
InterpretationreasoningThe accuracy of Global Burden of Disease 2016 bladder cancer incidence data may differ across countries because not all countries maintain nationwide cancer registries or because of discrepancies with national databases.
“Accuracy may differ, since not all keep nationwide cancer registries or there may be discrepancies with national databases.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenThe quality of Romanian THM data was low, with few published studies and very low population coverage, and may not reflect the current national average.
“However, the quality of THM data for Romania was low (few published studies with very low population coverage) and may not accurately reflect the current country average.”
Quote in the paperSubstantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome case-control studies show higher bladder cancer risks in women than in men.
“there are also case–control studies showing higher risks in women than men (Beane Freeman et al. 2017)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Beane Freeman et al. 2017
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBladder cancer incidence is expected to increase in some European countries and decrease in others over the next decade.
“the bladder cancer incidence is expected to increase in some European countries and decrease in others over the next decade (Antoni et al. 2017; Wong et al. 2018)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Antoni et al. 2017
Not checked in the free run.
- cites Wong et al. 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDisinfectants are highly reactive, and any one of them will form DBPs.
“Disinfectants are highly reactive by definition, and any one of them will lead to the formation of DBPs (Hua and Reckhow 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hua and Reckhow 2007
Not checked in the free run.
May combine two claims.
PremisecitationTHMs occur in mixtures with other DBPs, and their effects cannot be fully separated.
“are present in mixtures with other DBPs and their effects cannot be fully separated (Rice et al. 2009)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rice et al. 2009
Not checked in the free run.
- Rests on an assumption: THMs are an adequate surrogate for total DBP exposure despite their limitations.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenNational averages may conceal within-country disparities, such as lower THM levels in areas supplied by ground versus surface water.
“Although national averages may hide disparities within countries, i.e., areas supplied with ground vs. surface water may have lower THM levels”
Quote in the paperNot a substantial claim- Rests on an assumption: The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
May combine two claims.
InterpretationcitationThe pooled analysis by Costet et al. (2011) is the most comprehensive currently available, but it is limited to case-control studies and does not include a recent U.S. study.
“Although this is the most comprehensive pooled analysis currently available, it is limited to case–control studies and does not include a recent U.S. study of 1,213 bladder cancer cases and 1,418 controls (Beane Freeman et al. 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Costet et al. (2011)
Not checked in the free run.
- cites Beane Freeman et al. 2017
Not checked in the free run.
May combine two claims.
Study design and conductreasoningThe models were adjusted for main bladder cancer risk factors, but residual confounding cannot be ruled out.
“Although models are adjusted for the main risk factors of bladder cancer, the potential for residual confounding cannot be ruled out.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
There is no published report on current THM exposure levels in the European Union.
“there is no published report on current levels of exposure in the European Union.”
The authors state this as an assumption.
THM exposure is causally associated with bladder cancer.
“assuming a causal association”
The authors state this as an assumption.
PAF calculations treat everyone as exposed at the country's mean THM concentration, compared with a zero-exposure reference.
“assuming 100% exposure to the mean THM level (ORi) vs. no exposure (ORref=1.0)”
The paper relies on this without support.
The pooled exposure–response relationship from Costet et al. (2011) applies to European Union populations and to country-specific mean THM levels.
“We estimated population-attributable fractions (PAFs) for each country based on an exposure–response function derived using pooled data from an analysis of residential THM exposure and bladder cancer (Costet et al. 2011)”
The paper relies on this without support.
Routine monitoring THM measurements are representative of residential long-term THM exposure in each country.
“We obtained recent (2005–2018) information—with the exception of Austria (1997)—on THM levels in drinking water through routine monitoring for 26 of the 28 countries in the European Union”
The paper relies on this without support.
THM concentration is a valid marker or surrogate for total disinfection by-product exposure.
“THMs, used as a surrogate of DBPs”
The paper relies on this without support.
The country-specific average THM concentrations used in the burden calculation represent the exposure of the corresponding national populations.
“Although national averages may hide disparities within countries, i.e., areas supplied with ground vs. surface water may have lower THM levels, we prioritized width to depth in the data collection in order to compare the average situation between countries.”
The paper relies on this without support.
The exposure-response relationship between THMs and bladder cancer is causal and applies to the EU populations and age/sex groups used.
“Country-specific ORs were derived by converting the pooled OR for a 1-μg/L THM increment (OR=1.004), derived using pooled data for men and women age 30–80 from Costet et al. 2011) to a country-specific ORi for bladder cancer in association with the country-specific mean exposure vs. no exposure”
The paper relies on this without support.
THMs are an adequate surrogate for total DBP exposure despite their limitations.
“THMs have been used in epidemiological studies as surrogates of total DBP content. THMs have limitations as markers of total DBPs since they are not the most toxic (Plewa et al. 2008), are present in mixtures with other DBPs and their effects cannot be fully separated (Rice et al. 2009), and correlations with specific DBPs are variable (Villanueva et al. 2012).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Acute kidney injury, glomerulonephritis, diabetic nephropathy, and bladder cancer have been associated with exposure to pathological chlorination stress.
“Among other pathologies, acute kidney injury, glomerulonephritis, diabetic nephropathy, and bladder cancer have been associated with exposure to pathological chlorination stress (110, 162–166).”
From Hypochlorous Acid: From Innate Immune Factor and Environmental Toxicant to Chemopreventive Agent Targeting Solar UV-Induced Skin Cancer (2022) · cites this paper as [166]
Nephrotoxicity and urogenital tract dysfunction are established pathological outcomes of chlorination stress.
“Nephrotoxity and urogenital tract dysfunction are established pathological outcomes of chlorination stress.”
From Hypochlorous Acid: From Innate Immune Factor and Environmental Toxicant to Chemopreventive Agent Targeting Solar UV-Induced Skin Cancer (2022) · cites this paper as [166]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Bulgaria sensitivity contribution is understated
MinorBulgaria's 67 sensitivity-analysis attributable cases are about 1.2% of the stated EU total of 5,711, rather than 0.2%.
Reported 0.2 · recomputed 1.173175
“| Bulgaria | 6,028,262 | 1,468 | 11.7d | 1.048 (1.024, 1.072) | 4.6 (2.3, 6.8) | 67 (34, 99) | 1.0% | 4.6 (2.3, 6.8) | 67 (34, 99) | 0.2% |”
Table 5's title gives a different EU THM mean
MinorThe Table 5 title states 11.9 μg/L, whereas its reduced-exposure entries and note use 11.7 μg/L as the cap.
“Table: Table 5 Estimated number of attributable bladder cancer (BC) cases if no country would exceed the current EU total trihalomethanes (THM) mean level (11.9μg/L)”
“Note: Note: Reduced scenario: no country exceeds the current EU THM mean (11.7μg/L);”
Czech Republic sensitivity contribution is overstated tenfold
MinorThe Czech Republic's 138 sensitivity-analysis attributable cases are about 2.4% of the stated EU total of 5,711, not 24%.
Reported 24 · recomputed 2.416389
“| Czech Republic | 8,566,358 | 2,764 | 12.8 | 1.052 (1.026, 1.080) | 5.0 (2.5, 7.4) | 138 (70, 204) | 2.1% | 5.0 (2.5, 7.4) | 138 (70, 204) | 24% |”
The two tables give different totals for annual bladder cancer cases
MinorBoth tables describe EU28 men and women aged 20 years and above, but Table 3 reports 134,976 annual bladder cancer cases while Table 5 reports 123,805. Table 5 retains the same 6,561 attributable cases, so the conflicting denominator also affects interpretation of the reported burden.
“| Total EU28 | 404,672,106 | 134,976 | 11.7g | — | 4.9 (2.5, 7.1) | 6,561 (3,389, 9,537)”
“| Total EU28 | 123,805 | 11.7 | 6,561 (3,389, 9,537) | 7.5 | 3,693 (1,867, 5,478) | 2,868 (1,522, 4,060) | 43.7 | 100.0 |”
The pooled analysis is described as containing both six and seven studies
MinorThe methods repeatedly identify six case-control studies as the source of the pooled data, but the discussion says the same case and control counts came from seven studies.
“This is an international pooled analysis and meta-analysis including six case–control studies: two from the United States”
“We used pooled data for 3,481 cases and 5,977 controls from 7 case–control studies included in a meta-analysis by Costet et al. (2011)”
Spain's odds ratio lies outside its reported confidence interval
MinorThe point estimate of 1.122 exceeds its stated upper 95% confidence limit of 1.118.
“Spain | 37,275,483 | 13,648 | 28.8 | 1.122”
“1.122 (1.059, 1.118)”
Hungary and Slovakia have different odds-ratio intervals for the same exposure
MinorBoth rows give a mean THM level of 10.0 μg/L and a point odds ratio of 1.041, but Hungary's lower confidence limit is 1.041 while Slovakia's is 1.020. Their reported PAF intervals are identical.
“Hungary | 7,976,719 | 2,250 | 10.0 | 1.041 (1.041, 1.062) | 3.9 (2.0, 5.8)”
“Slovakia | 4,350,449 | 957 | 10.0 | 1.041 (1.020, 1.062) | 3.9 (2.0, 5.8)”
Cites
Wood, S. N. (2006) · doi:10.1201/9781420010404 · Cited by 4,953 · see citing works
RICHARDSON, S., PLEWA, M., WAGNER, E., SCHOENY, R., & DEMARINI, D. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.09.001 · Cited by 3,317 · see citing works
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017) · European Urology · doi:10.1016/j.eururo.2016.06.010 · Cited by 2,514 · see citing works
von Gunten, U. (2003) · Water Research · doi:10.1016/s0043-1354(02)00458-x · Cited by 1,345 · see citing works
IARC (International Agency for Research on Cancer)
Toporcov, T. N., & Filho, V. W. (2018) · Cited by 1,178 · see citing works
Comparison of disinfection byproduct formation from chlorine and alternative disinfectants
Hua, G., & Reckhow, D. A. (2007) · Water Research · doi:10.1016/j.watres.2007.01.032 · Cited by 737 · see citing works
Villanueva, C. M., Cantor, K. P., Grimalt, J. O., Malats, N., Silverman, D., Tardon, A., Garcia-Closas, R., Serra, C., Carrato, A., Castano-Vinyals, G., et al. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj364 · Cited by 596 · see citing works
Self-citationDisinfection Byproducts and Bladder Cancer: A Pooled Analysis
Villanueva, C. M., Cantor, K. P., Cordier, S., Jaakkola, J. J. K., King, W. D., Lynch, C. F., Porru, S., & Kogevinas, M. (2004) · Epidemiology · doi:10.1097/01.ede.0000121380.02594.fc · Cited by 522 · see citing works
Self-citationDrinking Water Source and Chlorination Byproducts I. Risk of Bladder Cancer
Cantor, K. P., Lynch, C. F., Hildesheim, M. E., Dosemeci, M., Lubin, J. H., Alavanja, M. C. R., & Craun, G. F. (1998) · Epidemiology · doi:10.1097/00001648-199801000-00007 · Cited by 349 · see citing works
Comparative Mammalian Cell Toxicity of N-DBPs and C-DBPs
Plewa, M. J., Wagner, E. D., Muellner, M. G., Hsu, K.-M., & Richardson, S. D. (2008) · ACS symposium series · doi:10.1021/bk-2008-0995.ch003 · Cited by 325 · see citing works
The exposome in practice: Design of the EXPOsOMICS project
Vineis, P., Chadeau‐Hyam, M., Gmuender, H., Gulliver, J., Herceg, Z., Kleinjans, J. C. S., Kogevinas, M., Kyrtopoulos, S. Α., Nieuwenhuijsen, M. J., Phillips, D. H., et al. (2016) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2016.08.001 · Cited by 325 · see citing works
Self-citationWong, M. C. S., Fung, F. D. H., Leung, C., Cheung, W. W. L., Goggins, W. B., & Ng, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-19199-z · Cited by 308 · see citing works
Overview of Disinfection By-products and Associated Health Effects
Villanueva, C. M., Cordier, S., Font-Ribera, L., Salas, L. A., & Levallois, P. (2015) · Current Environmental Health Reports · doi:10.1007/s40572-014-0032-x · Cited by 291 · see citing works
Self-citationCase-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada)
King, W. D., & Marrett, L. D. (1996) · Cancer Causes & Control · doi:10.1007/bf00051702 · Cited by 271 · see citing works
Urban and Transport Planning Related Exposures and Mortality: A Health Impact Assessment for Cities
Mueller, N., Rueda, D. R., Basagaña, X., Cirach, M., Cole‐Hunter, T., Dadvand, P., Donaire-González, D., Foraster, M., Gascón, M., Martinez, D. R., et al. (2016) · Environmental Health Perspectives · doi:10.1289/ehp220 · Cited by 269 · see citing works
Occupational Exposures and Gastric Cancer
Parent, M., Siemiatycki, J., & Fritschi, L. (1998) · Epidemiology · doi:10.1097/00001648-199801000-00011 · Cited by 251 · see citing works
Cantor, K. P., Villanueva, C. M., Silverman, D. T., Figueroa, J. D., Real, F. X., Garcia-Closas, M., Malats, N., Chanock, S., Yeager, M., Tardon, A., et al. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002206 · Cited by 238 · see citing works
Self-citationBehavior of trihalomethanes and haloacetic acids in a drinking water distribution system
Rodríguez, M. J., Sérodes, J. B., & Levallois, P. (2004) · Water Research · doi:10.1016/j.watres.2004.08.018 · Cited by 233 · see citing works
Costet, N., Villanueva, C. M., Jaakkola, J. J. K., Kogevinas, M., Cantor, K. P., King, W. D., Lynch, C. F., Nieuwenhuijsen, M. J., & Cordier, S. (2011) · Occupational and Environmental Medicine · doi:10.1136/oem.2010.062703 · Cited by 231 · see citing works
Self-citationRichardson, S. D., Thruston, A. D., Caughran, T. V., Chen, P. H., Collette, T. W., Schenck, K. M., Lykins, B. W., Rav‐Acha, C., & Glezer, V. (2000) · Water Air & Soil Pollution · doi:10.1023/a:1005265509813 · Cited by 211 · see citing works
Jeong, C. H., Wagner, E. D., Siebert, V., Anduri, S., Richardson, S. D., Daiber, E. J., McKague, A. B., Kogevinas, M., Villanueva, C. M., Goslan, E. H., et al. (2012) · Environmental Science & Technology · doi:10.1021/es3024226 · Cited by 184 · see citing works
Self-citationMeta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer
Villanueva, C. M., Fernández, F., Malats, N., Grimalt, J. O., & Kogevinas, M. (2003) · Journal of Epidemiology and Community Health · doi:10.1136/jech.57.3.166 · Cited by 180 · see citing works
Self-citationHebert, A., Forestier, D., Lenes, D., Benanou, D., Jacob, S., Arfi, C., Lambolez, L., & Lévi, Y. (2010) · Water Research · doi:10.1016/j.watres.2010.02.004 · Cited by 164 · see citing works
Genotoxic effects in swimmers exposed to disinfection by-products in indoor swimming pools
Kogevinas, M., Villanueva, C. M., Font-Ribera, L., Liviac, D., Bustamante, M., Espinoza, F., Nieuwenhuijsen, M. J., Espinosa, A., Fernandez, P., DeMarini, D. M., et al. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1001959 · Cited by 144 · see citing works
Self-citationRegli, S. E., Chen, J., Messner, M. J., Elovitz, M. S., Letkiewicz, F. J., Pegram, R. A., Pepping, T., Richardson, S. D., & Wright, J. M. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b03547 · Cited by 119 · see citing works
Sorlini, S., Gialdini, F., Biasibetti, M., et al. (2014) · Water Research · doi:10.1016/j.watres.2014.01.038 · Cited by 103 · see citing works
Kristiana, I., Tan, J., Joll, C. A., Heitz, A., von Gunten, U., & Charrois, J. W. A. (2013) · Water Research · doi:10.1016/j.watres.2012.10.014 · Cited by 102 · see citing works
Occupational Risks of Bladder Cancer in France: A Multicentre Case-Control Study
Cordier, S., Clavel, J., Limasset, J. C., BOCCON-GIBOD, L., Moual, N. L., MANDEREAU, L., & Hémon, D. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.3.403 · Cited by 95 · see citing works
STEWART, C. A. J. (1981) · Science · doi:10.1126/science.7233203 · Cited by 93 · see citing works
Freeman, L. E. B., Cantor, K. P., Baris, D., Nuckols, J. R., Johnson, A. T., Colt, J. S., Schwenn, M. R., Ward, M. H., Lubin, J. H., Waddell, R. D., et al. (2017) · Environmental Health Perspectives · doi:10.1289/ehp89 · Cited by 85 · see citing works
Amjad, H., Hashmi, I., Rehman, M. S. U., et al. (2013) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2013.01.008 · Cited by 75 · see citing works
Charisiadis, P., Andra, S. S., Makris, K. C., Christophi, C. A., Skarlatos, D. P., Vamvakousis, V., Kargaki, S., & Stephanou, E. G. (2014) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2014.10.071 · Cited by 72 · see citing works
Self-citationKoivusalo, M. T., Hakulinen, T. R., Vartiainen, T., Pukkala, ., Jaakkola, J. J. K., & Tuomist, J. (1998) · American Journal of Epidemiology · doi:10.1093/aje/148.7.704 · Cited by 71 · see citing works
Self-citationExposure assessment for trihalomethanes in municipal drinking water and risk reduction strategy
Chowdhury, S. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.06.104 · Cited by 70 · see citing works
Villanueva, C. M., Castaño-Vinyals, G., Moreno, V., Carrasco-Turigas, G., Aragonés, N., Boldo, E., Ardanaz, E., Toledo, E., Altzibar, J. M., Zaldua, I., et al. (2012) · Environmental Research · doi:10.1016/j.envres.2012.02.002 · Cited by 68 · see citing works
Self-citationDemonstrating a Natural Origin of Chloroform in Groundwater Using Stable Carbon Isotopes
Hunkeler, D., Laier, T., Breider, F., & Jacobsen, O. S. (2012) · Environmental Science & Technology · doi:10.1021/es204585d · Cited by 63 · see citing works
Villanueva, C. M., Gràcia‐Lavedan, E., Bosetti, C., Righi, E., Molina, A. J., Martín, V., Boldo, E., Aragonés, N., Pérez‐Gómez, B., Pollán, M., et al. (2016) · Environmental Health Perspectives · doi:10.1289/ehp155 · Cited by 61 · see citing works
Self-citationEXPOsOMICS: final policy workshop and stakeholder consultation
Turner, M. C., Vineis, P., Seleiro, E., Dijmarescu, M., Balshaw, D. M., Bertollini, R., Chadeau‐Hyam, M., Gant, T. W., Gulliver, J., Jeong, A., et al. (2018) · BMC Public Health · doi:10.1186/s12889-018-5160-z · Cited by 49 · see citing works
Self-citationHousehold Cleaning Activities as Noningestion Exposure Determinants of Urinary Trihalomethanes
Charisiadis, P., Andra, S. S., Makris, K. C., Christodoulou, M., Christophi, C. A., Kargaki, S., & Stephanou, E. G. (2013) · Environmental Science & Technology · doi:10.1021/es404220z · Cited by 45 · see citing works
Self-citationChlorinated Drinking Water and Bladder Cancer: Effect of Misclassification on Risk Estimates
Lynch, C. F., Woolson, R. F., O’Gorman, T. W., & Cantor, K. P. (1989) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.1989.9935891 · Cited by 44 · see citing works
Rice, G. E., Teuschler, L. K., Bull, R. J., et al. (2009) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390802608890 · Cited by 41 · see citing works
Occurrence of DBPs in Drinking Water of European Regions for Epidemiology Studies
Krasner, S. W., Kostopoulou, M. N., Toledano, M. B., Wright, J., Patelarou, E., Kogevinas, M., Villanueva, C. M., Carrasco‐Turigas, G., Marina, L. S., Fernández‐Somoano, A., et al. (2016) · American Water Works Association · doi:10.5942/jawwa.2016.108.0152 · Cited by 39 · see citing works
Self-citationPalacios, M. (2000) · Water Research · doi:10.1016/s0043-1354(99)00191-8 · Cited by 36 · see citing works
Espín-Pérez, A., Font-Ribera, L., van Veldhoven, K., Krauskopf, J., Portengen, L., Chadeau‐Hyam, M., Vermeulen, R. C. H., Grimalt, J. O., Villanueva, C. M., Vineis, P., et al. (2017) · Environment International · doi:10.1016/j.envint.2017.10.003 · Cited by 34 · see citing works
Self-citationDisinfection by-product occurrence in selected European waters
Goslan, E. H., Krasner, S. W., Villanueva, C. M., et al. (2013) · AQUA - Water Infrastructure Ecosystems and Society · doi:10.2166/aqua.2013.017 · Cited by 23 · see citing works
Self-citationWright, J. M., Murphy, P. A., Nieuwenhuijsen, M. J., & Savitz, D. A. (2005) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2005.08.010 · Cited by 22 · see citing works
Corso, M., Galey, C., Seux, R., & Beaudeau, P. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081669 · Cited by 18 · see citing works
Self-citation(2007) · PubMed · Cited by 7 · see citing works
Long-term characterization of trihalomethane levels in drinking water
González, A. L., Morales‐Suárez‐Varela, M., Sagrado, S., Gimeno‐Clemente, N., Yusà, V., Requena, P. M., & Monleón, L. M. (2010) · Toxicological & Environmental Chemistry Reviews · doi:10.1080/02772240903090524 · Cited by 6 · see citing works
Variation of Trihalomethanes Concentration In Tetova's Drinking Water in the Autumn Season
Bujar, D. H., Vezi, D., Ismaili, M., et al. (2013) · Cited by 5 · see citing works
Limiter la formation des sous-produits de désinfection
Courcier, J. P., Decerle, D., Jédor, B., et al. (2014) · Techniques Sciences Méthodes · doi:10.1051/tsm/201406069 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Babayigit MA, 2016, Evaluation of the effects of disinfection methods on volatile organic pollutant levels and some physicochemical parameters of water, J Environ Prot Ecol, 17, 460
- Bujar DH, 2017, Seasonal variation of trihalomethanes concentration in Tetova’s drinking water (part B), World J Appl Environ Chem, 1, 42
- Cohl M, 2015, Trihalomethanes issues drinking water after chlorination treatment, Revista de chimie, 66, 1282
- Dirtu D, 2016, Occurrence and assessment of selected chemical contaminants in drinking water from Eastern Romania, Revista de chimie, 67, 2059
- EC (European Commission), 1998, Council directive of 3 November 1998 on the quality of water intended for human consumption. European Council Directive 98/83/EC, Off J Eur Communities, 330, 23
- EC, 2018, Proposal for a Directive of the European Parliament and of the Council on the quality of water intended for human consumption (recast), Off J Eur Communities, 64, 55
- Premazzi G, 1997, Exposure of the European Population to Trihalomethanes (THMs) in Drinking Water
- Thach TT, 2012, An analysis of trihalomethane levels in the distribution networks of three Romanian cities, Carpathian J Earth Environ Sci, 7, 81
Cited by
Sorted by citations
Brown, J., Acey, C. S., Anthonj, C., Barrington, D. J., Beal, C. D., Capone, D., Cumming, O., Pullen Fedinick, K., MacDonald Gibson, J., Hicks, B., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00006-2 · Cited by 121 · see citing works
Health and Environmental Impacts of Drinking Water Choices in Barcelona, Spain: A Modelling Study
Villanueva, C. M., Garfí, M., Milà, C., Olmos, S., Ferrer, I., & Tonne, C. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.148884 · Cited by 49 · see citing works
Self-citationSnell, J. A., Jandova, J., & Wondrak, G. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887220 · Cited by 37 · see citing works
- Authors
- Evlampidou, I., Font-Ribera, L., Rojas-Rueda, D., Gracia-Lavedan, E., Costet, N., Pearce, N., Vineis, P., Jaakkola, J. J. K., Delloye, F., Makris, K. C., Stephanou, E. G., Kargaki, S., Kozisek, F., Sigsgaard, T., Hansen, B., Schullehner, J., Nahkur, R., Galey, C., Zwiener, C., Vargha, M., Righi, E., Aggazzotti, G., Kalnina, G., Grazuleviciene, R., Polanska, K., Gubkova, D., Bitenc, K., Goslan, E. H., Kogevinas, M., & Villanueva, C. M.
- Affiliations
- Universitat Pompeu Fabra (ES)
- ISGlobal, Barcelona, Spain
- Inserm (FR)
- London School of Hygiene & Tropical Medicine (GB)
- Imperial College London (GB)
- University of Oulu (FI)
- Service Public de Wallonie (BE)
- Cyprus University of Technology (CY)
- University of Crete (GR)
- National Institute of Public Health, Prague, Czech Republic
- Aarhus University (DK)
- Geological Survey of Denmark and Greenland (DK)
- Ministry of Social Affairs (EE)
- Santé Publique France (FR)
- University of Tübingen (DE)
- National Public Health Center, Budapest, Hungary
- University of Modena and Reggio Emilia (IT)
- Public Health Division, Ministry of Health of the Republic Latvia, Health Inspectorate, Riga, Latvia
- Department of Environmental Sciences, Faculty of Natural Sciences, Vytautas Magnus University, Kaunas, Lithuania
- Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland
- Public Health Authority of the Slovak Republic (SK)
- National Institute of Public Health (SI)
- Cranfield University (GB)
- Corresponding author
- Villanueva, Cristina M.
- ORCID
- Evlampidou, Iro
- Font-Ribera, Laia
- Costet, Nathalie
- Pearce, Neil
- Vineis, Paolo
- Jaakkola, Jouni J.K.
- Makris, Konstantinos C.
- Stephanou, Euripides G.
- Kargaki, Sophia
- Sigsgaard, Torben
- Hansen, Birgitte
- Schullehner, Jörg
- Galey, Catherine
- Zwiener, Christian
- Righi, Elena
- Aggazzotti, Gabriella
- Goslan, Emma H.
- Kogevinas, Manolis
- Villanueva, Cristina M.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-01
- Volume
- 128
- Issue
- 1
- Pages
- 17001-17001
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- PMC
- PMC7015561
- OpenAlex
- W2999609260
- Semantic Scholar
- 778c81b2af6a09381ffc32f48981bb51a59ba0d1
- Cited by
- 178
- References
- 52
- Citations by year
- 2026: 16 · 2025: 28 · 2024: 23 · 2023: 34 · 2022: 29 · 2021: 23 · 2020: 24 · 2019: 1
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- Locations
- Environmental Health Perspectives (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- HAL (submittedVersion, public-domain)
- CERES (Cranfield University) (submittedVersion, cc-by)
- Ktisis at Cyprus University of Technology (Cyprus University of Technology) (submittedVersion, cc-by-nc-nd)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, public-domain)
- Vytautas Magnus University (submittedVersion)
- Funders
- Università degli Studi di Cagliari
- Centres de Recerca de Catalunya
- European Commission (308610)
- Institut National de la Santé et de la Recherche Médicale
- Universiteit Utrecht
- Generalitat de Catalunya
- Queen's University
- Università degli Studi di Palermo
- École des Hautes Études en Santé Publique
- Terveyden ja hyvinvoinnin laitos
- National Institutes of Health
- Medical Research Council (MR/S019669/1)
- National Cancer Institute
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Water Treatment and Disinfection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Physical Sciences › Environmental Science › Environmental Chemistry › Arsenic contamination and mitigation
- Keywords
- trihalomethanes, disinfection by-products, drinking water, bladder cancer, attributable burden, population attributable fraction, exposure-response relationship, water disinfection, water treatment, European Union
- MeSH terms
- Urinary Bladder Neoplasms, Environmental Exposure, Europe, European Union, Humans, Water Pollutants, Chemical, Water Purification, Trihalomethanes, Drinking Water
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review